Homburger advises ADC Therapeutics in its IPO on the New York Stock Exchange

On May 15, 2020, ADC Therapeutics listed its shares on the New York Stock Exchange (ticker symbol ADCT). ADCT is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of antibody drug conjugates. Through its IPO, at Usd 19 per share, ADCT raises gross proceeds of USD 267 m including greenshoe. At market close on the first day of trading, ADCT had a market capitalization of USD 2.1 bn. ADCT is the first Swiss company to go public in 2020.

The team

Homburger advises ADC Therapeutics. The team is led by partner Dieter Gericke (corporate and m&a – pictured) and includes partners Reto Heuberger and Stefan Oesterhelt (both tax), Benjamin Leisinger (banking and finance), as well as associates Daniel Häusermann, Estelle Piccard (both corporate and m&a), Olivier Baum (banking and finance), Manuel Dubach (tax) and junior associate Oliver Kneubühl (corporate and m&a).

Homburger advises ADC Therapeutics in its IPO on the New York Stock Exchange



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram